An OspC-specific monoclonal antibody passively protects mice from tick-transmitted infection by Borrelia burgdorferi B31.
about
Temporal changes in outer surface proteins A and C of the lyme disease-associated spirochete, Borrelia burgdorferi, during the chain of infection in ticks and miceBorrelia burgdorferi changes its surface antigenic expression in response to host immune responsesOuter-surface protein C of the Lyme disease spirochete: a protein induced in ticks for infection of mammalsComparison of protection in rabbits against host-adapted and cultivated Borrelia burgdorferi following infection-derived immunity or immunization with outer membrane vesicles or outer surface protein A.Fitness estimates from experimental infections predict the long-term strain structure of a vector-borne pathogen in the field.Lyme borreliosis in rhesus macaques: effects of corticosteroids on spirochetal load and isotype switching of anti-borrelia burgdorferi antibody.Conformational nature of the Borrelia burgdorferi B31 outer surface protein C protective epitope.Inhibition of Borrelia burgdorferi migration from the midgut to the salivary glands following feeding by ticks on OspC-immunized mice.Protection elicited by native outer membrane protein Oms66 (p66) against host-adapted Borrelia burgdorferi: conformational nature of bactericidal epitopes.Major histocompatibility complex class II-independent generation of neutralizing antibodies against T-cell-dependent Borrelia burgdorferi antigens presented by dendritic cells: regulation by NK and gammadelta T cells.Distinct regulatory pathways control expression of Borrelia burgdorferi infection-associated OspC and Erp surface proteinsBorrelia burgdorferi RevA antigen is a surface-exposed outer membrane protein whose expression is regulated in response to environmental temperature and pHLuxS-mediated quorum sensing in Borrelia burgdorferi, the lyme disease spirochete.Simultaneous coexpression of Borrelia burgdorferi Erp proteins occurs through a specific, erp locus-directed regulatory mechanism.Antigenic and genetic heterogeneity of Borrelia burgdorferi populations transmitted by ticks.Inferring epitopes of a polymorphic antigen amidst broadly cross-reactive antibodies using protein microarrays: a study of OspC proteins of Borrelia burgdorferiTemporal analysis of Borrelia burgdorferi Erp protein expression throughout the mammal-tick infectious cycle.Antibody-mediated disease remission in the mouse model of lyme borreliosis.Analysis of Borrelia burgdorferi Surface Proteins as Determinants in Establishing Host Cell InteractionsSpecificity and role of the Borrelia burgdorferi CtpA protease in outer membrane protein processing.Probing the Borrelia burgdorferi surface lipoprotein secretion pathway using a conditionally folding protein domainCoordinated expression of Borrelia burgdorferi complement regulator-acquiring surface proteins during the Lyme disease spirochete's mammal-tick infection cycle.Vaccination with the variable tick protein of the relapsing fever spirochete Borrelia hermsii protects mice from infection by tick-bite.An immune evasion mechanism for spirochetal persistence in Lyme borreliosis.Borrelia burgdorferi basic membrane proteins A and B participate in the genesis of Lyme arthritisVirulence of the Lyme disease spirochete before and after the tick bloodmeal: a quantitative assessment.The failure of immune response evasion by linear plasmid 28-1-deficient Borrelia burgdorferi is attributable to persistent expression of an outer surface protein.Essential protective role attributed to the surface lipoproteins of Borrelia burgdorferi against innate defencesConstruction and analysis of variants of a polyvalent Lyme disease vaccine: approaches for improving the immune response to chimeric vaccinogens.Evaluation of the Borrelia burgdorferi BBA64 protein as a protective immunogen in mice.Constitutive expression of outer surface protein C diminishes the ability of Borrelia burgdorferi to evade specific humoral immunity.Analysis of antibody response in humans to the type A OspC loop 5 domain and assessment of the potential utility of the loop 5 epitope in Lyme disease vaccine developmentBorrelia burgdorferi Manipulates Innate and Adaptive Immunity to Establish Persistence in Rodent Reservoir Hosts.Extracellular secretion of the Borrelia burgdorferi Oms28 porin and Bgp, a glycosaminoglycan binding protein.Surface localization determinants of Borrelia OspC/Vsp family lipoproteins.Variable manifestations, diverse seroreactivity and post-treatment persistence in non-human primates exposed to Borrelia burgdorferi by tick feeding.Epitope mapping of Borrelia burgdorferi OspC protein in homodimeric fold.Infection history of the blood-meal host dictates pathogenic potential of the Lyme disease spirochete within the feeding tick vector.
P2860
Q24550778-7D934EA3-D6C7-475F-8F85-74EED2EF59C1Q24561576-FA61CF88-62E2-40D2-938C-D4955447BE82Q24624698-CF9FE08A-B686-4A42-89CF-D28FF21060DAQ33598183-593F9154-8B53-42E0-A16E-8E01FA401F7AQ33686914-2694DF44-62CC-4AE2-B867-1F19AD6B7475Q33998927-FF19968D-CF7E-4D10-9523-738E0BD32762Q34002237-5E9E34D5-3CC9-4CFD-A6DA-1C0F29FF2C6AQ34003131-7DCBFE74-3407-4B2F-88EA-AC2D37AB9A9AQ34004241-7082DAF0-F3DE-439C-9095-D871C54864ABQ34006887-6CA7C45F-82AB-4025-85D4-33F95702DE31Q34008137-B543C278-D8C0-48D4-A147-FAC0F483B04BQ34008806-F6C0DC1F-AC8A-409C-99E8-2AECCB775382Q34128445-84969AA7-FAC6-42ED-9678-B51E2BD85601Q34316819-2AF75925-30CA-4AEF-999B-93C102F1B63FQ34625361-39694E6F-B7E4-45D9-A326-9E06E8BBC513Q34797227-4A5C4802-A8A9-49B9-A393-76CCCA1C8B1EQ34945715-0965C458-0A28-455F-AD97-1387FB10BACCQ34975726-407A0A2F-927C-4485-A841-15F2CCABA258Q35086019-BF52F01A-FA00-41CA-A3DF-F857151EC6B2Q35272739-A14FDA95-3CE5-479C-AD2C-798C72A7AA6CQ35598789-D6DBB1B7-243A-44CB-BF71-1E2EDCF96973Q35947203-F9EC8BB2-F263-47BC-89B4-842550EC7EE6Q36200147-894D9758-17C5-4D4B-8187-F8BFDDF9FF58Q36369900-64CFDF81-DD39-4A0D-92D6-F520A8DA7BCEQ36446924-86D64D1C-E291-44AF-BA77-BACC103CC0EEQ36657384-8A39533F-E8EF-4542-BEB9-4B8B19A40EDCQ36845230-4DB0C9B6-1B43-4FEB-99DE-6B4DD87FEC49Q36953212-6430FEB3-B34F-4187-895D-558A8DE03D27Q37228833-7ADEF1FB-2C41-4F05-B392-746DEFF8688DQ37712830-D5EDF462-5513-49E2-A8F9-C504662E1690Q38481937-4D5BAC32-FDFD-4749-80C1-1EB55D475353Q38499117-59782B15-6486-4667-917E-65551A92C72CQ39164585-048EA2D9-4A89-4865-A27A-69F976A6DF68Q40206647-77CF2D4F-9590-4257-92A0-42367D77D987Q40329766-3B0943B9-818C-41A9-B635-5294B1191ADDQ46181782-9F9C5930-449F-4715-8AC5-EAE6E6DEC377Q51159971-B3FD6D7A-F8D6-4976-8018-C1EA7C5483D0Q52330933-A8F5CEE6-3178-4646-AF23-23D6E4C53A7D
P2860
An OspC-specific monoclonal antibody passively protects mice from tick-transmitted infection by Borrelia burgdorferi B31.
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
An OspC-specific monoclonal an ...... n by Borrelia burgdorferi B31.
@ast
An OspC-specific monoclonal an ...... n by Borrelia burgdorferi B31.
@en
An OspC-specific monoclonal an ...... n by Borrelia burgdorferi B31.
@nl
type
label
An OspC-specific monoclonal an ...... n by Borrelia burgdorferi B31.
@ast
An OspC-specific monoclonal an ...... n by Borrelia burgdorferi B31.
@en
An OspC-specific monoclonal an ...... n by Borrelia burgdorferi B31.
@nl
prefLabel
An OspC-specific monoclonal an ...... n by Borrelia burgdorferi B31.
@ast
An OspC-specific monoclonal an ...... n by Borrelia burgdorferi B31.
@en
An OspC-specific monoclonal an ...... n by Borrelia burgdorferi B31.
@nl
P2093
P2860
P921
P1476
An OspC-specific monoclonal an ...... on by Borrelia burgdorferi B31
@en
P2093
P2860
P304
P407
P577
1999-10-01T00:00:00Z